Please login to the form below

Not currently logged in
Email:
Password:

off label

This page shows the latest off label news and features for those working in and with pharma, biotech and healthcare.

CAR-Ts Kymriah and Yescarta  step closer to approval  in Europe

CAR-Ts Kymriah and Yescarta  step closer to approval  in Europe

The CHMP says it recommends adding this uses to its licensed indications, as it is would otherwise have to be used off-label, and is also  obliging Novartis and Gilead to

Latest news

More from news
Approximately 4 fully matching, plus 179 partially matching documents found.

Latest Intelligence

  • Significant figures Significant figures

    Fast forward to last September and the company’s decision to put ALIS through phase III trials paid off, when it released late-stage results showing 29% of patients with NTM ... or less off-label as it’s not specifically indicated to treat the

  • Healthcare systems

    Healthcare terms - Healthcare systems.

  • The gold standard of scientific evidence The gold standard of scientific evidence

    More than one in five prescriptions in the United States are for an off-label use; providing additional evidence to better understand treatment efficacy and safety is crucial.

  • Creative marketing and compliance Creative marketing and compliance

    Sales people can be using marketing content in good faith, without realising that it is 'off label' and unapproved. ... Get it wrong and not only is there the risk of being 'off brand' (it could even be a matter of life or death), but local regulations

  • Does safety sell medicines? Does safety sell medicines?

    New legislation in Europe introduced in 2012 has also led companies to expand what they collect from just side effects to reports of occupational exposure, off-label use and medication errors. ... Through the collection and review of adverse event

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics